IDO1 and infectious otitis media: Immunohistochemical analysis also revealed that, in AOM/DSS-treated rats, the expression levels of IDO1 in both CRC tissues and the non-lesional mucosal cells were significantly decreased upon RQ-15986 administration (Fig 5B and 5C).